Neil A. Klompas

Chief Financial Officer, Zymeworks.

Companies

InMed Pharmaceuticals Inc.Board member Oct 17, 2025 to now¹
ZymeworksChief operating officer Jan 6, 2023 to Mar 14, 2023²
ZymeworksPresident Jan 6, 2023 to Mar 14, 2023²
ZymeworksChief operating officer Jan 7, 2022 to Jul 5, 2022³
ZymeworksChief financial officer Jan 2, 2019 to Jan 7, 2022⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInMed Pharmaceuticals Inc., Board member
2
SEC EDGARZymeworks, Chief operating officer
3
SEC EDGARZymeworks, Chief operating officer
4
SEC EDGARZymeworks, Chief financial officer